{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"NCRI Conference, ASCO Annual Meeting, and Perspectives in Lung Cancer European Congress","description":"New research for advanced NSCLC showing that combining monoclonal antibodies  and chemotherapy can extend life: OTBN Editor Peter Goodwin and Producer Sarah  Maxwell talk to Robert Pirker, Christian Manegold, Giorgio  Scagliotti, Nick Thatcher, and Howard Sandler, MD. PLUS:  Michel Coleman on the latest findings from the CONCORD study of  international differences in survival rates for breast, prostate, and colorectal  cancers.","author_name":"OT Broadcast News","author_url":"http:\/\/www.oncology-times.com","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/1109847\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/item\/1109847"}